Name | Number of supported studies | Average coverage | |
---|---|---|---|
ciliated cell | 16 studies | 28% ± 9% | |
fibroblast | 14 studies | 24% ± 9% | |
epithelial cell | 10 studies | 33% ± 14% | |
goblet cell | 9 studies | 44% ± 21% | |
adipocyte | 9 studies | 34% ± 7% | |
endothelial cell | 7 studies | 25% ± 6% | |
respiratory goblet cell | 6 studies | 31% ± 9% | |
glutamatergic neuron | 6 studies | 45% ± 24% | |
club cell | 6 studies | 24% ± 6% | |
pericyte | 6 studies | 27% ± 10% | |
type II pneumocyte | 6 studies | 28% ± 14% | |
GABAergic neuron | 6 studies | 39% ± 20% | |
neuron | 5 studies | 31% ± 13% | |
transit amplifying cell | 5 studies | 25% ± 9% | |
mucus secreting cell | 5 studies | 38% ± 12% | |
smooth muscle cell | 5 studies | 19% ± 2% | |
interneuron | 5 studies | 35% ± 22% | |
pancreatic A cell | 4 studies | 38% ± 26% | |
plasma cell | 4 studies | 32% ± 9% | |
luminal cell of prostate epithelium | 4 studies | 21% ± 5% | |
type I pneumocyte | 4 studies | 22% ± 5% | |
oligodendrocyte precursor cell | 4 studies | 29% ± 7% | |
macrophage | 4 studies | 23% ± 4% | |
astrocyte | 4 studies | 24% ± 7% | |
oligodendrocyte | 4 studies | 25% ± 6% | |
type B pancreatic cell | 3 studies | 52% ± 27% | |
GABAergic interneuron | 3 studies | 19% ± 3% | |
microglial cell | 3 studies | 22% ± 2% | |
mesothelial cell | 3 studies | 20% ± 3% | |
secretory cell | 3 studies | 22% ± 7% | |
basal cell | 3 studies | 31% ± 4% | |
mast cell | 3 studies | 18% ± 2% |
Tissue | GTEx Coverage | GTEx Average TPM | GTEx Number of samples | TCGA Coverage | TCGA Average TPM | TCGA Number of samples |
---|---|---|---|---|---|---|
prostate | 100% | 5045.73 | 245 / 245 | 100% | 108.22 | 502 / 502 |
esophagus | 100% | 3176.58 | 1444 / 1445 | 100% | 70.04 | 183 / 183 |
lung | 100% | 5408.81 | 577 / 578 | 100% | 61.62 | 1153 / 1155 |
intestine | 100% | 5805.63 | 966 / 966 | 100% | 99.36 | 525 / 527 |
pancreas | 100% | 5401.90 | 328 / 328 | 99% | 57.38 | 177 / 178 |
stomach | 100% | 5384.45 | 359 / 359 | 99% | 89.24 | 284 / 286 |
breast | 100% | 6030.71 | 459 / 459 | 99% | 75.00 | 1109 / 1118 |
ovary | 100% | 3626.47 | 180 / 180 | 96% | 28.42 | 414 / 430 |
bladder | 100% | 3499.71 | 21 / 21 | 96% | 53.55 | 483 / 504 |
uterus | 100% | 3885.21 | 170 / 170 | 95% | 39.65 | 438 / 459 |
thymus | 100% | 6284.41 | 653 / 653 | 94% | 54.71 | 568 / 605 |
kidney | 100% | 3073.01 | 89 / 89 | 92% | 33.68 | 831 / 901 |
skin | 99% | 4127.38 | 1793 / 1809 | 93% | 34.73 | 438 / 472 |
adrenal gland | 100% | 3978.23 | 258 / 258 | 90% | 35.49 | 208 / 230 |
liver | 99% | 4100.42 | 223 / 226 | 83% | 24.42 | 339 / 406 |
brain | 91% | 1866.93 | 2396 / 2642 | 90% | 21.14 | 636 / 705 |
adipose | 100% | 7094.69 | 1204 / 1204 | 0% | 0 | 0 / 0 |
ureter | 0% | 0 | 0 / 0 | 100% | 23.31 | 1 / 1 |
blood vessel | 100% | 6171.36 | 1334 / 1335 | 0% | 0 | 0 / 0 |
spleen | 99% | 2084.56 | 239 / 241 | 0% | 0 | 0 / 0 |
muscle | 99% | 2147.42 | 792 / 803 | 0% | 0 | 0 / 0 |
heart | 93% | 2757.82 | 804 / 861 | 0% | 0 | 0 / 0 |
tonsil | 0% | 0 | 0 / 0 | 82% | 22.00 | 37 / 45 |
lymph node | 0% | 0 | 0 / 0 | 52% | 10.88 | 15 / 29 |
eye | 0% | 0 | 0 / 0 | 51% | 12.11 | 41 / 80 |
peripheral blood | 32% | 2335.08 | 297 / 929 | 0% | 0 | 0 / 0 |
abdomen | 0% | 0 | 0 / 0 | 0% | 0 | 0 / 0 |
bone marrow | 0% | 0 | 0 / 0 | 0% | 0 | 0 / 0 |
diaphragm | 0% | 0 | 0 / 0 | 0% | 0 | 0 / 0 |
gingiva | 0% | 0 | 0 / 0 | 0% | 0 | 0 / 0 |
nasal cavity | 0% | 0 | 0 / 0 | 0% | 0 | 0 / 0 |
nasopharynx | 0% | 0 | 0 / 0 | 0% | 0 | 0 / 0 |
nose | 0% | 0 | 0 / 0 | 0% | 0 | 0 / 0 |
placenta | 0% | 0 | 0 / 0 | 0% | 0 | 0 / 0 |
spinal column | 0% | 0 | 0 / 0 | 0% | 0 | 0 / 0 |
GO_0006048 | Biological process | UDP-N-acetylglucosamine biosynthetic process |
GO_0006002 | Biological process | fructose 6-phosphate metabolic process |
GO_0032922 | Biological process | circadian regulation of gene expression |
GO_0006541 | Biological process | glutamine metabolic process |
GO_0006047 | Biological process | UDP-N-acetylglucosamine metabolic process |
GO_0006487 | Biological process | protein N-linked glycosylation |
GO_0006112 | Biological process | energy reserve metabolic process |
GO_0070062 | Cellular component | extracellular exosome |
GO_0005829 | Cellular component | cytosol |
GO_0004360 | Molecular function | glutamine-fructose-6-phosphate transaminase (isomerizing) activity |
GO_0097367 | Molecular function | carbohydrate derivative binding |
Gene name | GFPT1 |
Protein name | glutamine--fructose-6-phosphate transaminase (isomerizing) (EC 2.6.1.16) Glutamine--fructose-6-phosphate aminotransferase [isomerizing] 1 (EC 2.6.1.16) (D-fructose-6-phosphate amidotransferase 1) (Glutamine:fructose-6-phosphate amidotransferase 1) (GFAT 1) (GFAT1) (Hexosephosphate aminotransferase 1) Glutamine--fructose-6-phosphate transaminase 1 |
Synonyms | GFPT GFAT |
Description | FUNCTION: Controls the flux of glucose into the hexosamine pathway. Most likely involved in regulating the availability of precursors for N- and O-linked glycosylation of proteins. Regulates the circadian expression of clock genes BMAL1 and CRY1 (By similarity). Has a role in fine tuning the metabolic fluctuations of cytosolic UDP-GlcNAc and its effects on hyaluronan synthesis that occur during tissue remodeling . . |
Accessions | A0A6I8PRT6 ENST00000494201.1 A0A6I8PTT9 ENST00000674438.1 ENST00000361060.5 [Q06210-2] A0A6I8PRN4 ENST00000357308.9 [Q06210-1] ENST00000674507.1 Q06210 |